Please Wait.....
Report
Middle East and Africa Multiplexed Diagnostics Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 140 Pages I EMR Inc.
Middle East and Africa Multiplexed Diagnostics Market Report and Forecast 2024-2032
Middle East and Africa Multiplexed Diagnostics Market Size
The global multiplexed diagnostics market was valued at USD 12.9 billion in 2023, with the Middle East and Africa holding a significant market share. The market is driven by the growing demand for multiplexed assays in clinical diagnostics. It is expected to grow at a CAGR of 15.2% during the forecast period of 2024-2032, with the values likely to attain USD 46.2 billion by 2032.
Middle East and Africa Multiplexed Diagnostics Market Outlook
- The market share is influenced by the rising expansion efforts of the key market players in the emerging economies. In March 2022 , a leading manufacturer of digital PCR (dPCR) diagnostics Stilla Technologies signed deals with multiple distributors including Alliance Global in the Gulf and Africa, among others, to expand its reach into the Middle East and Africa region.
- One of the major Middle East and Africa multiplexed diagnostics market trends is the rise in regulatory approval of advanced multiplexed tests. For instance, in February 2023, BGI Genomics' multiplex bacterial resistance genes detection kit and multiplex nucleic acid kit for respiratory pathogens received market authorization from the Saudi Food & Drug Authority (SFDA).
- The increased application of multiplexed assays in clinical diagnostics and infectious disease surveillance is expected to augment the market demand in the region.
Middle East and Africa Multiplexed Diagnostics Market Analysis
Multiplexed diagnostics allows the simultaneous detection and analysis of nucleic acids, proteins, or other biomolecules in a single test. These techniques can detect several targets from a single sample resulting in reduced sample volume and faster results. Multiplexed diagnostics are increasingly used in clinical diagnostics and infectious disease surveillance to facilitate early disease detection and monitoring. The rising adoption of these advanced assays in healthcare settings to improve diagnostic workflows and reduce turnaround times is expected to significantly contribute to the Middle East and Africa multiplexed diagnostics market growth.
The market is impacted by the presence of a favourable regulatory environment which facilitates the introduction of innovative multiplexed diagnostic products in the region. In February 2023, BGI Genomics , a global provider of genetic tests and sequencing services, announced that its PM Easy Lab products including multiplex bacterial resistance genes detection kit and multiplex nucleic acid kit for respiratory pathogens have received market authorization from the Saudi Food & Drug Authority (SFDA). The market access to these multiplexed tests in Saudi Arabia is likely to advance clinical diagnosis and encourage the informed use of antibiotics, which is poised to augment the Middle East and Africa multiplexed diagnostics market demand.
The market is also influenced by the rising expansion efforts of the key market players. This growing market penetration increases the availability and accessibility of multiplexed diagnostic products and services in these emerging economies, thereby boosting the market share. For instance, in March 2022 , a leading biotechnology company Stilla Technologies signed deals with multiple distributors including Alliance Global in the Gulf and Africa, among others, to expand its reach into the Middle East and Africa region. The agreement offered distribution rights to Stilla's product portfolio such as the six-color naica system, a next-generation multiplexing digital polymerase chain reaction (PCR) platform, to the partnering companies. Such developments are anticipated to accelerate the market growth by fuelling the adoption of multiplexed diagnostics in clinical laboratories.
Middle East and Africa Multiplexed Diagnostics Market Segmentation??
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Reagents and Consumables
Instruments
Others
Market Breakup by Application
Disease Diagnostics
Drug Development
Molecular Diagnostics
Others
Market Breakup by Technology
Low Density Multiplexed Assays
Medium Density Multiplexed Assays
High Density Multiplexed Assays
Very High Density Multiplexed Assays
Next-Generation Sequencing Assays
Others
Market Breakup by End User
Hospitals
Clinical Laboratories
Academic and Research Institutes
Diagnostic Centers
Others
Market Breakup by Country
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Leading Players in the Middle East and Africa Multiplexed Diagnostics Market
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific Inc.
- Luminex Corporation
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN N.V.
- Abbott Laboratories
- Siemens Healthineers
- Agilent Technologies
- bioMerieux SA
- Hoffmann-La Roche Ltd
- Eurofins Scientific SE
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What is the Middle East and Africa multiplexed diagnostics market forecast outlook for 2024-2032?
The Middle East and Africa multiplexed diagnostics market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 15.2% during the forecast period of 2024-2032 and is likely to reach a market value of USD 46.2 billion by 2032.
- What are the major factors aiding the Middle East and Africa multiplexed diagnostics market demand?
The rising demand for innovative multiplexed assays in clinical laboratories is fuelling the demand for the market.
- What are the major Middle East and Africa multiplexed diagnostics market trends?
One of the significant trends in the market is the rise in regulatory approval of advanced multiplexed tests. For instance, in February 2023, BGI Genomics' multiplex bacterial resistance genes detection kit and multiplex nucleic acid kit for respiratory pathogens received market authorization from the Saudi Food & Drug Authority (SFDA).
- What is the market segmentation based on the product type?
Based on the product type, the market is segmented into reagents, consumables, and instruments, among others.
- What is the market breakup by technology?
By technology, the market is divided into low density multiplexed assays, medium density multiplexed assays, high density multiplexed assays, very high-density multiplexed assays, and next-generation sequencing assays, among others.
- What are the major end users of the market?
End users of the market are hospitals, clinical laboratories, academic & research institutes, and diagnostics centers, others.
- What are the applications of the multiplexed diagnostics?
Major applications of multiplexed diagnostics include disease diagnostics, drug development, and molecular diagnostics, among others.
- What is the market segmentation by countries?
The market segmentation by countries includes Saudi Arabia, the United Arab Emirates, Nigeria, and South Africa, among others.
- Who are the key players involved in the Middle East and Africa multiplexed diagnostics market?
The key players in the market are Thermo Fisher Scientific Inc., Luminex Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Abbott Laboratories, Siemens Healthineers, Agilent Technologies, bioMerieux SA, Hoffmann-La Roche Ltd, and Eurofins Scientific SE.
Meta description
The Middle East and Africa multiplexed diagnostics market is poised for growth, driven by the expansion of the global market, which was valued at USD 12.9 billion in 2023 and is projected to grow at a CAGR of 15.2% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Middle East and Africa Multiplexed Diagnostics Market Overview
3.1 Middle East and Africa Multiplexed Diagnostics Market Historical Value (2017-2023)
3.2 Middle East and Africa Multiplexed Diagnostics Market Forecast Value (2024-2032)
4 Middle East and Africa Multiplexed Diagnostics Market Landscape*
4.1 Middle East and Africa Multiplexed Diagnostics: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Middle East and Africa Multiplexed Diagnostics: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Delivery Model
5 Middle East and Africa Multiplexed Diagnostics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Middle East and Africa Multiplexed Diagnostics Market Segmentation (2017-2032)
6.1 Middle East and Africa Multiplexed Diagnostics Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Reagents & Consumables
6.1.3 Instruments
6.1.4 Others
6.2 Middle East and Africa Multiplexed Diagnostics Market (2017-2032) by Technology
6.2.1 Market Overview
6.2.2 Low Density Multiplexed Assays
6.2.3 Medium Density Multiplexed Assays
6.2.4 High Density Multiplexed Assays
6.2.5 Very High-Density Multiplexed assays
6.2.6 Next-Generation Sequencing Assays
6.2.7 Others
6.3 Middle East and Africa Multiplexed Diagnostics Market (2017-2032) by Application
6.3.1 Market Overview
6.3.2 Disease Diagnostics
6.3.3 Drug Development
6.3.4 Molecular Diagnostics
6.3.5 Others
6.4 Middle East and Africa Multiplexed Diagnostics Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinical Laboratories
6.4.4 Academic & Research Institutes
6.4.5 Diagnostics Centers
6.4.6 Others
6.5 Middle East and Africa Multiplexed Diagnostics Market (2017-2032) by Countries
6.5.1 Market Overview
6.5.2 Saudi Arabia
6.5.3 United Arab Emirates
6.5.4 Nigeria
6.5.5 South Africa
6.5.6 Others
7 Saudi Arabia Multiplexed Diagnostics Market (2017-2032)
7.1 Saudi Arabia Multiplexed Diagnostics Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Reagents & Consumables
7.1.3 Instruments
7.1.4 Others
7.2 Saudi Arabia Multiplexed Diagnostics Market (2017-2032) by Technology
7.2.1 Market Overview
7.2.2 Low Density Multiplexed Assays
7.2.3 Medium Density Multiplexed Assays
7.2.4 High Density Multiplexed Assays
7.2.5 Very High-Density Multiplexed assays
7.2.6 Next-Generation Sequencing Assays
7.2.7 Others
7.3 Saudi Arabia Multiplexed Diagnostics Market (2017-2032) by Application
7.3.1 Market Overview
7.3.2 Disease Diagnostics
7.3.3 Drug Development
7.3.4 Molecular Diagnostics
7.3.5 Others
7.4 Saudi Arabia Multiplexed Diagnostics Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Clinical Laboratories
7.4.4 Academic & Research Institutes
7.4.5 Diagnostics Centers
7.4.6 Others
8 United Arab Emirates Multiplexed Diagnostics Market (2017-2032)
8.1 United Arab Emirates Multiplexed Diagnostics Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Reagents & Consumables
8.1.3 Instruments
8.1.4 Others
8.2 United Arab Emirates Multiplexed Diagnostics Market (2017-2032) by Technology
8.2.1 Market Overview
8.2.2 Low Density Multiplexed Assays
8.2.3 Medium Density Multiplexed Assays
8.2.4 High Density Multiplexed Assays
8.2.5 Very High-Density Multiplexed assays
8.2.6 Next-Generation Sequencing Assays
8.2.7 Others
8.3 United Arab Emirates Multiplexed Diagnostics Market (2017-2032) by Application
8.3.1 Market Overview
8.3.2 Disease Diagnostics
8.3.3 Drug Development
8.3.4 Molecular Diagnostics
8.3.5 Others
8.4 United Arab Emirates Multiplexed Diagnostics Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Hospitals
8.4.3 Clinical Laboratories
8.4.4 Academic & Research Institutes
8.4.5 Diagnostics Centers
8.4.6 Others
9 Nigeria Multiplexed Diagnostics Market (2017-2032)
9.1 Nigeria Multiplexed Diagnostics Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Reagents & Consumables
9.1.3 Instruments
9.1.4 Others
9.2 Nigeria Multiplexed Diagnostics Market (2017-2032) by Technology
9.2.1 Market Overview
9.2.2 Low Density Multiplexed Assays
9.2.3 Medium Density Multiplexed Assays
9.2.4 High Density Multiplexed Assays
9.2.5 Very High-Density Multiplexed assays
9.2.6 Next-Generation Sequencing Assays
9.2.7 Others
9.3 Nigeria Multiplexed Diagnostics Market (2017-2032) by Application
9.3.1 Market Overview
9.3.2 Disease Diagnostics
9.3.3 Drug Development
9.3.4 Molecular Diagnostics
9.3.5 Others
9.4 Nigeria Multiplexed Diagnostics Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Hospitals
9.4.3 Clinical Laboratories
9.4.4 Academic & Research Institutes
9.4.5 Diagnostics Centers
9.4.6 Others
10 South Africa Multiplexed Diagnostics Market (2017-2032)
10.1 South Africa Multiplexed Diagnostics Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Reagents & Consumables
10.1.3 Instruments
10.1.4 Others
10.2 South Africa Multiplexed Diagnostics Market (2017-2032) by Technology
10.2.1 Market Overview
10.2.2 Low Density Multiplexed Assays
10.2.3 Medium Density Multiplexed Assays
10.2.4 High Density Multiplexed Assays
10.2.5 Very High-Density Multiplexed assays
10.2.6 Next-Generation Sequencing Assays
10.2.7 Others
10.3 South Africa Multiplexed Diagnostics Market (2017-2032) by Application
10.3.1 Market Overview
10.3.2 Disease Diagnostics
10.3.3 Drug Development
10.3.4 Molecular Diagnostics
10.3.5 Others
10.4 South Africa Multiplexed Diagnostics Market (2017-2032) by End User
10.4.1 Market Overview
10.4.2 Hospitals
10.4.3 Clinical Laboratories
10.4.4 Academic & Research Institutes
10.4.5 Diagnostics Centers
10.4.6 Others
11 Regulatory Framework
12 Funding and Investment Analysis
12.1 Analysis by Funding Instances
12.2 Analysis by Type of Funding
12.3 Analysis by Funding Amount
12.4 Analysis by Leading Players
12.5 Analysis by Leading Investors
12.6 Analysis by Geography
13 Partnership and Collaborations Analysis
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Supplier Landscape
14.1 Market Share by Top 5 Companies
14.2 THERMO FISHER SCIENTIFIC INC.
14.2.1 Financial Analysis
14.2.2 Product Portfolio
14.2.3 Demographic Reach and Achievements
14.2.4 Mergers and Acquisitions
14.2.5 Certifications
14.3 LUMINEX CORPORATION
14.3.1 Financial Analysis
14.3.2 Product Portfolio
14.3.3 Demographic Reach and Achievements
14.3.4 Mergers and Acquisitions
14.3.5 Certifications
14.4 ILLUMINA, Inc.
14.4.1 Financial Analysis
14.4.2 Product Portfolio
14.4.3 Demographic Reach and Achievements
14.4.4 Mergers and Acquisitions
14.4.5 Certifications
14.5 BIO-RAD LABORATORIES, Inc.
14.5.1 Financial Analysis
14.5.2 Product Portfolio
14.5.3 Demographic Reach and Achievements
14.5.4 Mergers and Acquisitions
14.5.5 Certifications
14.6 QIAGEN N.V.
14.6.1 Financial Analysis
14.6.2 Product Portfolio
14.6.3 Demographic Reach and Achievements
14.6.4 Mergers and Acquisitions
14.6.5 Certifications
14.7 ABBOTT LABORATORIES
14.7.1 Financial Analysis
14.7.2 Product Portfolio
14.7.3 Demographic Reach and Achievements
14.7.4 Mergers and Acquisitions
14.7.5 Certifications
14.8 SIEMENS HEALTHINEERS
14.8.1 Financial Analysis
14.8.2 Product Portfolio
14.8.3 Demographic Reach and Achievements
14.8.4 Mergers and Acquisitions
14.8.5 Certifications
14.9 AGILENT TECHNOLOGIES
14.9.1 Financial Analysis
14.9.2 Product Portfolio
14.9.3 Demographic Reach and Achievements
14.9.4 Mergers and Acquisitions
14.9.5 Certifications
14.10 BIOMERIEUX SA
15.10.1 Financial Analysis
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
14.11 HOFFMANN-LA ROCHE LTD
14.11.1 Financial Analysis
14.11.2 Product Portfolio
14.11.3 Demographic Reach and Achievements
14.11.4 Mergers and Acquisitions
14.11.5 Certifications
14.12 EUROFINS SCIENTIFIC SE
14.12.1 Financial Analysis
14.12.2 Product Portfolio
14.13.3 Demographic Reach and Achievements
14.14.4 Mergers and Acquisitions
14.15.5 Certifications
15 Middle East and Africa Multiplexed Diagnostics Market - Distribution Model (Additional Insight)
15.1 Overview
15.2 Potential Distributors
15.3 Key Parameters for Distribution Partner Assessment
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
17 Company Competitiveness Analysis (Additional Insight)
17.1 Very Small Companies
17.2 Small Companies
17.3 Mid-Sized Companies
17.4 Large Companies
17.5 Very Large Companies
18 Payment Methods (Additional Insight)
18.1 Government Funded
18.2 Private Insurance
18.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security